We are live on ! Find out more
PCM

Perkins Capital Management Portfolio holdings

AUM $133M
1-Year Est. Return 127.86%
This Fund
S&P 500
This Quarter Est. Return
+19.7%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
AUM
$117M
AUM Growth
+$16.2M
Cap. Flow
+$781K
Cap. Flow %
0.67%
Top 10 Hldgs %
40.41%
Holding
101
New
3
Increased
31
Reduced
35
Closed
9

Sector Composition

Rank Sector Weight
1 Healthcare 50.04%
2 Technology 27.4%
3 Industrials 10.52%
4 Communication Services 6.23%
5 Consumer Staples 3.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLUS icon
51
ePlus
PLUS
$2.54B
$719K 0.61%
9,000
-500
-5% -$33.4K
CSTL icon
52
Castle Biosciences
CSTL
$953M
$694K 0.59%
32,140
+2,980
+10% +$52.4K
RMTI icon
53
Rockwell Medical
RMTI
$29.9M
$661K 0.56%
34,993
+27,489
+366% +$516K
T icon
54
AT&T
T
$160B
$655K 0.56%
39,042
+2,500
+7% +$39.5K
USB icon
55
US Bancorp
USB
$100B
$649K 0.55%
14,984
VZ icon
56
Verizon
VZ
$195B
$626K 0.53%
16,617
+1,500
+10% +$53.1K
FAST icon
57
Fastenal
FAST
$57B
$622K 0.53%
19,200
DCI icon
58
Donaldson
DCI
$11.4B
$581K 0.5%
8,884
-1,000
-10% -$60.9K
NXPI icon
59
NXP Semiconductors
NXPI
$59.9B
$563K 0.48%
2,450
APYX icon
60
Apyx Medical
APYX
$180M
$559K 0.48%
213,500
+1,700
+0.8% +$4.12K
ANIP icon
61
ANI Pharmaceuticals
ANIP
$1.8B
$507K 0.43%
9,191
AKTS
62
DELISTED
Akoustis Technologies Inc
AKTS
$506K 0.43%
606,652
+9,152
+2% +$6.15K
BLFS icon
63
BioLife Solutions
BLFS
$1.59B
$504K 0.43%
31,000
CVS icon
64
CVS Health
CVS
$133B
$457K 0.39%
5,793
+500
+9% +$35.6K
LFVN icon
65
LifeVantage
LFVN
$86.2M
$457K 0.39%
76,113
OPCH icon
66
Option Care Health
OPCH
$3.55B
$371K 0.32%
11,000
-1,500
-12% -$46.1K
MRNA icon
67
Moderna
MRNA
$22.8B
$368K 0.31%
+3,700
New +$311K
BP icon
68
BP
BP
$109B
$366K 0.31%
10,350
+3,200
+45% +$117K
JNJ icon
69
Johnson & Johnson
JNJ
$614B
$353K 0.3%
2,250
SHIM icon
70
Shimmick
SHIM
$175M
$343K 0.29%
+52,000
New +$325K
ASUR icon
71
Asure Software
ASUR
$254M
$314K 0.27%
33,000
IMGN
72
DELISTED
Immunogen Inc
IMGN
$308K 0.26%
10,400
-1,700
-14% -$33.9K
RNG icon
73
RingCentral
RNG
$5.09B
$306K 0.26%
9,025
-2,500
-22% -$74.7K
CATX icon
74
Perspective Therapeutics
CATX
$342M
$281K 0.24%
70,000
-197,164
-74% -$555K
IONS icon
75
Ionis Pharmaceuticals
IONS
$9.15B
$281K 0.24%
5,550

Similar funds

Perkins Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Perkins Capital Management held 101 positions worth $117M, up 16% from $101M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Perkins Capital Management's Q4 2023 filing shows 3 new, 31 increased, 35 reduced and 9 closed positions. Its largest new stake was Digital Turbine: 186,200 shares worth $1.28M. The largest sale was Perion Network, an estimated $1.05M.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, down from 52% a quarter earlier, followed by Technology and Industrials.

  • Perkins Capital Management's largest Q4 2023 buy was Digital Turbine: 186,200 shares worth $1.28M.
  • Perkins Capital Management added most to Airgain in Q4 2023, an estimated $1.15M increase.
  • Perkins Capital Management's biggest Q4 2023 reduction was Perion Network, cutting an estimated $1.05M.
  • Perkins Capital Management fully exited Achieve Life Sciences in Q4 2023, selling an estimated $538K.
  • Perkins Capital Management's ten largest holdings make up 40% of its $117M portfolio in Q4 2023.
  • Perkins Capital Management opened 3 new positions and closed 9 in Q4 2023.
  • Perkins Capital Management's portfolio value rose 16% quarter-over-quarter to $117M.

Based on Perkins Capital Management's 13F filing for Q4 2023, filed 22 Jan 2024.